Many Investors Still Treating Gilead: 4 Launches This Year Could Prove Them Wrong
Gilead sits at a crossroads: the HIV backbone remains strong, but a quartet of new launches could reshape the company...
Learn how to identify key budget categories and monitor them effectively. A concise guide to staying on top of your spending and maximizing savings.
24,745 articlesGilead sits at a crossroads: the HIV backbone remains strong, but a quartet of new launches could reshape the company...
A $1,000 invest? here’s what XRP and Bitcoin could be worth by 2027, depending on regulatory outcomes for XRP and mac...
U.S. oil refiners are set for a historic profit surge as supply disruptions and stronger demand push refining margins...
AST SpaceMobile dropped about 13% in early trading after pricing a $1 billion convertible offering and signaling pote...
As spacemobile nears commercial launch, investors wonder if this space-based cellular plan can disrupt the market. Th...
Apple is leaning into a capital-light AI model that runs on-device and with trusted partners. This story explains why...
Berkshire Hathaway slashed its Amazon holding by 77% in the fourth quarter, leaving a lean position and sparking rene...
As remitly gears up for 2025, investors should focus on growth drivers, margin potential, and the risks that could sh...
OpenAI has redefined its mission and governance, moving into a for-profit structure and removing safety language from...
A diversified ETF bundles 38 clean-energy names into a single exposure, aiming for long-term growth as policy timelin...
Explore how Permian Resources could navigate 2025 earnings, debt reduction, and growth opportunities. Learn who benef...
As markets swing and newcomers crowd the fintech scene, 2026 could determine whether Robinhood finally builds a durab...